Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3392 (113th)

Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013

referredUnited States· United States Congress· EN

Introduced

30 October 2013

Last action

1 November 2013 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Bilirakis, Gus M. [R-FL-12], Sen. Luján, Ben Ray [D-NM], Rep. Rogers, Harold [R-KY-5], Rep. Whitfield, Ed [R-KY-1], Rep. Long, Billy [R-MO-7], Rep. Ross, Dennis A. [R-FL-15]

Subjects

Healthcare

Source updated

12 August 2025

Healthcare

Summary

Medicare Part D Patient Safety and Drug Abuse Prevention Act of 2013 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to establish a safe pharmacy access program under which a prescription drug plan (PDP) sponsor (or a Medicare Advantage (MA) organization offering an MA-PD plan) shall have in place procedures designed to prevent fraud and abuse in the dispensing of certain controlled substances under Medicare part D. Allows a PDP sponsor to suspend payments and clean claim notifications to a pharmacy pending an investigation of a credible allegation of fraud against the pharmacy, unless the Secretary determines there is a good cause not to suspend payments. Directs the Secretary of Health and Human Services (HHS), under contracts entered into under the Medicare integrity program with Medicare drug integrity contractors (MEDICs), to authorize such MEDICs to obtain prescription and medical records directly from entities such as pharmacies, PDPs, and physicians. Requires a MEDIC to acknowledge receipt of a PDP sponsor referral of information for investigation, report back to the sponsor the investigation results within 45 days, and share them with appropriate agencies. Requires electronic transmission (e-prescribing) of prescriptions for certain covered Medicare part D controlled substances.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 30 October 2013

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 30 October 2013

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 30 October 2013

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 1 November 2013

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 30 October 2013

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 30 October 2013

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 30 October 2013

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.